Harvard Bioscience(US:HBIO)2026-03-06 16:02Summary of Harvard Bioscience Special Meeting Company Overview - Company: Harvard Bioscience (NasdaqGM: HBIO) - Meeting Date: March 6, 2026 Key Points Meeting Proceedings - The meeting was called to order by John Duke, President, CEO, and Director of Harvard Bioscience, with a quorum established for conducting business [1][4] - Stockholders were reminded that only those logged in with a valid control number could vote and submit questions [2] Proposals Discussed 1. Reverse Stock Split Proposal - The first item of business was to approve an amendment to the company's Second Amended and Restated Certificate of Incorporation for a reverse stock split at a ratio between 1 for 5 and 1 for 15, with the final ratio to be determined by the board of directors [4] - The board unanimously recommended that stockholders vote in favor of this proposal [4] 2. Adjournment Proposal - The second item was to approve the adjournment or postponement of the Special Meeting if necessary to continue soliciting votes for the reverse stock split proposal [5] - The board also unanimously recommended that stockholders vote in favor of this proposal [5] Voting Results - Preliminary voting results indicated that 97.63% of votes cast were in favor of the reverse stock split proposal [6] - For the adjournment proposal, 97.71% of votes cast were in favor [6] - The final voting results will be published within four business days in a Form 8-K report to the Securities and Exchange Commission [7] Conclusion of Meeting - The meeting was adjourned after thanking stockholders for their support [8][9] - Any questions submitted by stockholders would be addressed separately [8] Additional Notes - The meeting was conducted virtually, and stockholders were provided with a web portal for participation and voting [2] - The presence of Broadridge Financial Solutions as the Inspector of Election was noted, ensuring impartiality in the voting process [3]